HIK Insider Trading

Insider Ownership Percentage: 30.54%
Insider Buying (Last 12 Months): £14,565.44
Insider Selling (Last 12 Months): GBX 0

Hikma Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Hikma Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
20222023202420250bought0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-40M-20M020M40MTotal Insider BuyingTotal Insider Selling

Hikma Pharmaceuticals Share Price & Price History

Current Price: GBX 2,088
Price Change: Price Increase of +4 (0.19%)
As of 01/21/2025 01:06 PM ET

This chart shows the closing price history over time for HIK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MarAprMayJunJulAugSepOctNovDecJan2,088.00Closing price on 01/21/25:

Hikma Pharmaceuticals Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Hikma Pharmaceuticals (LON:HIK)

42.09% of Hikma Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Hikma Pharmaceuticals logo
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly. We are a trusted, reliable partner and dependable source of over 670 (as of 31 December 2021) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 32 manufacturing facilities, 7 R&D centres and 8,700+ employees worldwide.
Read More on Hikma Pharmaceuticals

Today's Range

Now: GBX 2,088
Low: 2,080
High: 2,112

50 Day Range

MA: GBX 1,954.23
Low: 1,794
High: 2,091.92

52 Week Range

Now: GBX 2,088
Low: 1,750
High: 2,165

Volume

272,171 shs

Average Volume

1,506,988 shs

Market Capitalization

£4.63 billion

P/E Ratio

3,212.31

Dividend Yield

3.25%

Beta

0.41

Who are the company insiders with the largest holdings of Hikma Pharmaceuticals?

Hikma Pharmaceuticals' top insider shareholders include:
  1. Douglas Hurt (Insider)
  2. Riad Mishlawi (Insider)
Learn More about top insider investors at Hikma Pharmaceuticals.